It is well-accepted that many prostate cancer cases, particularly those diagnosed through prostate-specific antigen (PSA) screening, have microscopic foci of limited (i.e., non-life-threatening) clinical relevance, and research suggests that more aggressive and fatal prostate malignancies have etiologies distinct from indolent disease [2–4]. The gene discussed is KLK3; the disease is Familial prostate cancer.